19.7.2019 The EU and the USA reach a milestone on the mutual recognition of GMP inspections of pharmaceutical manufacturers

4.7.2019 Fimea to host a number of pharmaceutical meetings during Finland's Presidency

1.7.2019 Fimea issued Fysioline Oy with a marketing ban decision concerning the use of starter packs of the Trampalgin medicinal product in marketing

27.6.2019 Cannabidiol (CBD) is controlled as a medicine in Finland

26.6.2019 Fimea welcomes requests to act as RMS

11.6.2019 Meds75+ database now available for use as open data

10.6.2019 Automatic substitution of biological medicines would be possible if carefully planned and gradually implemented

7.6.2019 Patient organisations endorse the establishment of a patient advisory board

15.5.2019 Physicians hold a largely positive view of the uptake of biosimilars

10.5.2019 Respond to the Fimea customer satisfaction survey